• Moderators, please send me a PM if you are unable to access mod permissions. Thanks, Habsy.

OT: Coronavirus Resources - and other things to not worry about

also apparently the trade names for the different vaccines are not a thing.

when my friends/family asked me what I got for my booster and I said "spikevax" they all thought I was pulling their leg.
 
it's funny you mention him because we are subscribers to the Halifax Examiner, and the first place I went to look after your post was their covid update from yesterday, which is entirely fact driven with no opinion/editorializing.

now, I know that Tim has strong views and I am sure they are apparent in his questions but in terms of what is actually reported on the Examiner's site as news, I cannot take any issue with.

but I hear you as the few media updates I have listened to are basically a series of questions from the media trying to get Strang/Houston/Rankin to explain why they are not doing what x reporter or y soccer mom thinks they ought to be, force them to justify the rules or decision a vs b, etc.
Yeah. I pay for it too. His questions... His manner... Like his writing more than his voice.
 

I found this to be a very interesting read. It is a bit on the long side but I found it worth the minute or two it took me to read it.

It presents a few scenarios on triage ethics and the unvaccinated. I think I know which one I would very reluctantly have to choose but fortunately I won’t have to.
 
Impressive growth advantage. Might explain why Denmark isn't peaking just yet.




As I said, they're pretty distinct from each other. So reinfections are possible though I'd imagine having 3 doses as well will help. The article says this has already happened in Norway. Omicron specific boosters pls.
 
https://www.nature.com/articles/d41586-022-00112-8?s=09

Other antiviral drug candidates are slowly working their way through the clinical-trial pipeline, says Carl Dieffenbach, director of the division of AIDS at the US National Institute of Allergy and Infectious Diseases (NIAID). He says that one promising candidate is a protease inhibitor, developed by Shionogi & Company, based in Osaka, Japan, and Hokkaido University in Japan, that is currently in phase II/III clinical trials in Asia. The candidate targets the same protease as Paxlovid but would only require patients to take a single pill each day.

That simpler regimen could help to avert the rise of resistance, Cherry says. Unfinished treatments can hasten drug resistance by allowing the virus to develop defences against the drug while it continues multiplying and wreaking havoc in the body. Both molnupiravir and Paxlovid consist of several pills that must be taken twice a day for five consecutive days. “The second you have people taking something multiple times a day when they’re sick is when you have issues with compliance,” Cherry says.




I'm on #TeamPaxlovid but there are a lot of limitations! 2nd gen products will hopefully change that!
 
#TeamNaturalInfection takes a bit of a hit here. Wide confidence interval with that + booster data but still



Important to remember that "what doesn't kill you sometimes makes you a lot weaker.
 
Anyone elses twitter feed full of the trucker antivax bs? The last few days mine is littered with people I dont follow whining about stopping trucker vax mandates
 
Back
Top